TOMMASI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 242
NA - Nord America 181
AS - Asia 50
Totale 473
Nazione #
US - Stati Uniti d'America 181
IE - Irlanda 87
IT - Italia 73
CN - Cina 46
SE - Svezia 35
AT - Austria 15
DE - Germania 8
FI - Finlandia 7
BE - Belgio 4
CZ - Repubblica Ceca 3
ES - Italia 3
PL - Polonia 3
PT - Portogallo 2
SG - Singapore 2
FR - Francia 1
GB - Regno Unito 1
HK - Hong Kong 1
JP - Giappone 1
Totale 473
Città #
Dublin 87
Chandler 57
Ashburn 25
Shanghai 23
Parma 19
Beijing 17
Vienna 15
New York 14
Bologna 9
Boardman 7
Ravenna 7
Bremen 6
Milan 6
Princeton 6
Seattle 6
Des Moines 5
Sassuolo 5
Cascina 4
Helsinki 4
Collecchio 3
Reggio Emilia 3
Wilmington 3
Brussels 2
Fremont 2
Lisbon 2
Los Angeles 2
Madrid 2
Scarperia e San Piero 2
Torrile 2
Woodbridge 2
Ann Arbor 1
Corno di Rosazzo 1
Fairfield 1
Gambettola 1
Hong Kong 1
Leuven 1
London 1
Miami 1
Modena 1
Molenbeek-Saint-Jean 1
Olomouc 1
Piacenza 1
Prague 1
Redmond 1
Rio Saliceto 1
Roseland 1
Sassari 1
Shenzhen 1
Singapore 1
Taglio Di Po 1
Tokyo 1
Trieste 1
Totale 369
Nome #
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 48
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers 48
The future potential of genome-wide mutational profiles in HRD detection in breast cancer 48
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review 45
A review of immune checkpoint blockade in breast cancer 38
My best choice after a round trip from illness 34
A narrative review of the principal glucocorticoids employed in cancer 34
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma 30
Synchronous and metachronous colorectal liver metastases: Impact of primary tumor location on patterns of recurrence and survival after hepatic resection 26
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer 25
The Innate Immune Microenvironment in Metastatic Breast Cancer 22
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? 21
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score 21
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing 21
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome? 13
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 8
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies 7
Abscopal effect as part of treatment of oligometastatic head and neck cancer: A case report 5
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study 4
Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals 3
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study 2
Totale 503
Categoria #
all - tutte 2.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.691


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 0 13 0 0
2021/202244 0 0 5 6 4 4 7 2 0 1 0 15
2022/2023262 22 18 17 14 37 27 3 14 88 2 15 5
2023/2024184 7 29 3 3 14 35 23 14 12 26 18 0
Totale 503